Below is a list of forthcoming submissions that have recently been added to the SMC work programme.

• Abiraterone acetate (Zytiga)
• Alemtuzumab (Lemtrada)
• Alogliptin benzoate (Vipidia)
• Aztreonam lysine (Cayston)
• Brentuximab vedotin (Adcetris)
• Brinzolomide with brimonidine tartrate (Simbranza)
• Empagliflozin (Jardiance)
• Everolimus (Afinitor)
• Golimumab (Simponi)
• Ipilimumab (Yervoy)
• Lurasidone (Latuda)
• Pemetrexed disodium heptahydrate (Alimta)
• Pertuzumab (Perjeta)
• Riociguat (Adempas)
• Tocilizumab (RoActemra)
• Trastuzumab emtansine (Kadcyla)

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions